SHANGHAI, Jan 30 (Reuters) - Sciwind Biosciences' type 2 diabetes treatment Xianyida was approved for use in China, the company said on Friday, adding another participant to a hot sector in the ...

Association driven by fewer major amputations ...

Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...

The City of El Paso Department of Public Health (DPH) is offering free A1C testing to the community on “Take Charge Tuesdays” ...

Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D)—but which genes and proteins are ...

Recent advances in diabetes detection may help to identify risk earlier. In this article, MNT discusses recent studies that ...

An international study co-led by researchers from the University of Massachusetts Amherst and Helmholtz Munich in Germany has ...

Is your backside trying to tell you something? New research suggests that the shape of the GM — not just the size — could be ...

By Tarun Sai Lomte From rising obesity and diabetes to stubborn health inequities, the AHA’s latest statistics reveal why ...

Around 12.1% of Black Americans have diabetes compared with about 6.9% of non-Hispanic White adults, according to the ...

The Indiana House reversed course on an effort to repeal “Hunter’s Law.” The 2007 law provides additional protection for kids ...

Alexander Zverev booked a third straight Australian Open semifinal on Tuesday, outlasting Learner Tien 6-3, 6-7(5), 6-1, ...